Literature DB >> 9498284

Heterologous expression of rat P450 2E1 in a mammalian cell line: in situ metabolism and cytotoxicity of N-nitrosodimethylamine.

H L Lin1, E S Roberts, P F Hollenberg.   

Abstract

GM0637, a human fibroblast cell line, was transfected with pCMV2E1, an expression vector containing the full length cDNA for rat cytochrome P450 2E1 (P450 2E1), and with pCMVneo, which contained vector alone, and the selected clones were designated GM2E1 and GMneo, respectively. Western blot analysis showed that GM2E1, but not GMneo, expressed a protein that reacted with anti-human P450 2E1 antibody. The 7-ethoxycoumarin O-deethylase,p-nitrophenol hydroxylase, and N-nitrosodimethylamine (NDMA) demethylase activities of the P450 in these cells were measured in monolayer cell cultures without preparing microsomes. Exposure of the GM2E1 cells to NDMA for 4 days caused severe decreases in cell viability, as determined by crystal violet uptake, and showed a sigmoidal dose-response curve with a median lethal dose of 17 microM. In contrast, the viability of GMneo cells was not altered by NDMA even at concentrations up to 10 mM. Time- and concentration-dependent methylation of DNA, RNA and protein by [14C]NDMA was only observed in cells expressing P450 2E1. Inhibitors of P450 2E1 activity such as ethanol, 4-methylpyrazole, and isoniazid caused a 90% decrease in the methylation of cellular macromolecules and also completely protected the cells against NDMA-mediated toxicity. The cytotoxicity due to exposure to NDMA was partially inhibited by antioxidants such as N-acetylcysteine, ascorbic acid, butylated hydroxyanisole and N-t-butyl-alpha-phenylnitrone but was not potentiated upon glutathione depletion. These results document the ability of rat P450 2E1 to metabolize NDMA to toxic reactive intermediates and demonstrate that this cell line provides a useful model for studying the mechanisms of metabolism-mediated toxicity and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498284     DOI: 10.1093/carcin/19.2.321

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  5 in total

1.  Cytochrome P450 Genes (CYP2E1 and CYP1A1) Variants and Susceptibility to Chronic Hepatitis B Virus Infection.

Authors:  Sadegh Fattahi; Mohammad Karimi Alivije; Farhang Babamahmoodi; Masomeh Bayani; Mahmoud Sadeghi Haddad Zavareh; Mohsen Asouri; Maryam Lotfi; Galia Amirbozorgi; Haleh Akhavan-Niaki
Journal:  Indian J Clin Biochem       Date:  2017-09-23

2.  Establishment of a human hepatoma cell line, HLE/2E1, suitable for detection of p450 2E1-related cytotoxicity.

Authors:  I Nozaki; T Tsuji; M Sakaguchi; Y Inoue; R Hirai; A Andou; M Miyazaki; N Shimizu; M Namba
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-10       Impact factor: 2.416

3.  Heterologous expression of human cytochrome P450 2E1 in HepG2 cell line.

Authors:  Jian Zhuge; Ye Luo; Ying-Nian Yu
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 4.  CYP2E1 and oxidative liver injury by alcohol.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  Free Radic Biol Med       Date:  2007-11-17       Impact factor: 7.376

5.  Expression of CYP2E1 in human nasopharynx and its metabolic effect in vitro.

Authors:  De-Fu Hou; Shui-Liang Wang; Zhi-Min He; Fang Yang; Zhu-Chu Chen
Journal:  Mol Cell Biochem       Date:  2006-12-05       Impact factor: 3.842

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.